RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-19 5:46 pm Sale |
2025-05-15 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 2,134,806 4.900% |
-2,028,470 (-48.72%) |
Filing |
| 2025-05-14 6:34 pm Purchase |
2025-05-12 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 4,163,276 9.900% |
504,230 (+13.78%) |
Filing |
| 2024-05-14 9:10 pm Sale |
2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 3,659,046 9.990% |
-758,213 (-17.16%) |
Filing |
| 2020-08-05 4:30 pm Purchase |
2009-02-28 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 4,417,259 13.200% |
4,417,259 (New Position) |
Filing |